Pharmacokinetics of nicotinic acid-salicylic acid interaction. 1989

R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
Division of Clinical Pharmacology, Heidelberg University Medical Center, West Germany.

Both nicotinic acid and salicylic acid undergo glycine conjugation in human beings. Competitive inhibition may therefore be possible when these substances are used concomitantly in patients with hyperlipidemic disorders. The aim of this study was to determine, in six healthy subjects, whether nicotinic acid steady-state levels and total clearance are affected by concomitant aspirin administration. Steady-state nicotinic acid concentrations were obtained in all six volunteers by infusion of nicotinic acid solutions at constant rates (0.075 to 0.100 mg/kg/min) for 6 hours; aspirin (1 gm) was administered orally 120 minutes after the beginning of the infusion of nicotinic acid. Plasma samples were analyzed for nicotinic acid, nicotinuric acid, and salicylic acid. After aspirin administration an immediate marked decrease of nicotinuric acid levels could be observed in all six volunteers, whereas nicotinic acid concentrations increased. We hypothesize that salicylic acid causes a concentration-dependent decrease of total nicotinic acid clearance that results in the saturation (and effective elimination) of the nicotinuric acid conjugation pathway.

UI MeSH Term Description Entries
D007260 Infusion Pumps Fluid propulsion systems driven mechanically, electrically, or osmotically that are used to inject (or infuse) over time agents into a patient or experimental animal; used routinely in hospitals to maintain a patent intravenous line, to administer antineoplastic agents and other drugs in thromboembolism, heart disease, diabetes mellitus (INSULIN INFUSION SYSTEMS is also available), and other disorders. Drug Infusion Systems,Infusion Pump,Infusion Pumps, External,Infusors,Intravenous Drug Delivery System,Intravenous Drug Delivery Systems,Perfusion Pumps,Pumps, Infusion,Drug Infusion System,External Infusion Pump,External Infusion Pumps,Infusion Pump, External,Infusion System, Drug,Infusion Systems, Drug,Infusor,Perfusion Pump,Pump, External Infusion,Pump, Infusion,Pump, Perfusion,Pumps, External Infusion,Pumps, Perfusion,System, Drug Infusion,Systems, Drug Infusion
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012459 Salicylates The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis. Salicylate,Salicylic Acids,Acids, Salicylic

Related Publications

R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
November 1976, Archives of dermatology,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
March 1991, Journal of veterinary pharmacology and therapeutics,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
January 1979, Drug metabolism reviews,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
November 1968, Journal of pharmaceutical sciences,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
January 1985, Drugs under experimental and clinical research,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
August 1993, Journal of pharmacokinetics and biopharmaceutics,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
September 2012, Biopharmaceutics & drug disposition,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
June 1994, Journal of pharmaceutical sciences,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
June 2006, International journal of clinical practice,
R W Ding, and K Kolbe, and B Merz, and J de Vries, and E Weber, and L Z Benet
September 1979, Digestive diseases and sciences,
Copied contents to your clipboard!